MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Budesonide

CAS No. : 51333-22-3

产品活性：Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma.

研究领域：Immunology/Inflammation  |  Vitamin D Related/Nuclear Receptor

作用靶点：Glucocorticoid Receptor

In Vitro: Budesonide is selective for human glucocorticoid receptor (hGR; EC₅₀=45.7 pM) over mineralocorticoid receptors (EC₅₀=7,620 pM) in CV-1 cells.
Budesonide (30 min prior to LPS) suppresses the activation of the NLRP3 inflammasome by LPS (100 ng/mL) plus ATP (5 mM) in macrophages (RAW 264.7 cells).

In Vivo: Budesonide (2.0 mg/kg; orally via their diet; at 2, 7 and 21 days prior to killing) decreases the size of lung tumors.
Budesonide (0.5 mg/kg; intranasal administration 1 h before LPS injection (5 mg/kg)) pretreatment dramatically attenuates pathological injury and reduces pathological scores in mice with ALI in adult male C57BL/6 mice.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Tumorigenesis-Related Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Nuclear Receptor Compound Library  |  Non-steroidal Anti-Inflammatory Compound Library  |  Pain-Related Compound Library  |  Off-patent Drug Library  |  Medroxyprogesterone acetate-d₃  |  Prednisolone acetate  |  Clobetasone butyrate  |  Mifepristone-¹³C,d₃  |  Deflazacort  |  C108297  |  Nenocorilant  |  Methylprednisolone succinate  |  Medroxyprogesterone acetate  |  Betamethasone 21-phosphate-d₅  |  Betamethasone dipropionate-d₁₀  |  Fluticasone propionate-d₅  |  Methylprednisolone-d₅  |  Fluticasone furoate-d₃  |  Dexamethasone-d₄  |  Mizacorat  |  Beclometasone dipropionate  |  Mifepristone-d₃  |  Methylprednisolone-d₂  |  Beclometasone dipropionate-d₁₀  |  Prednisone-d₈  |  Prednisolone Tebutate  |  Hydrocortisone hemisuccinate  |  Betamethasone-d₅-1  |  OP-3633  |  Glucocorticoid receptor agonist-1  |  Triamcinolone Benetonide

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种*仅有化合物库，我们致力于为*科研客户提供前沿的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果；
•   专业团队跟踪新的制药及生命科学研究进展，为您提供*新的活性化合物；
•   与世界各大制药公司及*科研机构建立了长期的合作。